NCT06631417View on ClinicalTrials.gov

A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

January 10, 2025

Study Completion Date

May 14, 2025

Conditions
Healthy
Interventions
DRUG

BI 1291583

formulation 1

DRUG

BI 1291583

formulation 2

DRUG

BI 1291583

formulation 3

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY